Arcus Capital Partners, LLC Aziyo Biologics, Inc. Transaction History
Arcus Capital Partners, LLC
- $212 Million
- Q3 2025
A detailed history of Arcus Capital Partners, LLC transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Arcus Capital Partners, LLC holds 30,050 shares of AZYO stock, worth $43,572. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,050
Previous 30,050
-0.0%
Holding current value
$43,572
Previous $43,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding AZYO
# of Institutions
29Shares Held
17MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.18MShares$4.62 Million0.2% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.17MShares$4.59 Million0.76% of portfolio
-
Silverarc Capital Management, LLC2.76MShares$4 Million0.97% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.64MShares$3.83 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$1.71 Million0.0% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...